Drug Trial Radar · NCT03521934
Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Last checked: Nov 20, 2026Latest source record: Oct 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,222
Actual
Start
Jun 15, 2018
Primary completion
Jun 5, 2020
Study completion Jun 5, 2020
Sponsor
- Lead sponsor
- Lexicon PharmaceuticalsIndustry
- Sponsor type
- Industry
- Collaborators
- Sanofi
- First posted
- May 11, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: To compare the effect of sotagliflozin to placebo on the total occurrences of cardiovascular (CV) death, hospitalization for heart failure (HHF), and urgent visit for heart failure (HF) in hemodynamically stable participants after admission for worsening heart failure (WHF) Secondary Objectives: To compare the effects of sotagliflozin to placebo on: * The total occurrences of HHF and urgent visit for HF * The occurrence of CV death * The occurrence of all-cause mortality * The total occurrences of CV death, HHF, urgent visit for HF, non-fatal myocardial infarction (MI), and non-fatal stroke * Change in Kansas City Cardiomyopathy Questionnaire-12(KCCQ-12) score * Change in estimated glomerular filtration rate (eGFR)
Conditions
- Heart Failure
- Type 2 Diabetes Mellitus
Interventions
SotagliflozinDrug
Pharmaceutical form: tablet Route of administration: oral
PlaceboDrug
Pharmaceutical form: tablet Route of administration: oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Total Occurrences of Cardiovascular (CV) Death, Hospitalizations for Heart Failure (HHF) and Urgent Visits for Heart Failure (HF)Time frame: Up to 21.9 months
Locations
466 sites in 32 countries. Site status is shown where the registry gives one.
Investigational Site Number 8400128
Alexander City, Alabama
Investigational Site Number 8400109
Cottonwood, Arizona
Investigational Site Number 8400032
Little Rock, Arkansas
Investigational Site Number 8400080
Little Rock, Arkansas
Investigational Site Number 8400075
Bakersfield, California
Investigational Site Number 8400069
Fresno, California
Investigational Site Number 8400008
Los Angeles, California
Investigational Site Number 8400063
Los Angeles, California
Investigational Site Number 8400127
National City, California
Investigational Site Number 8400007
Redondo Beach, California
Investigational Site Number 8400036
Stockton, California
Investigational Site Number 8400033
Sylmar, California
Investigational Site Number 8400049
Torrance, California
Investigational Site Number 8400028
Walnut Creek, California
Investigational Site Number 8400029
Bridgeport, Connecticut
Investigational Site Number 8400037
New Haven, Connecticut
Investigational Site Number 8400046
DeLand, Florida
Investigational Site Number 8400009
Gainesville, Florida
Investigational Site Number 8400079
Homestead, Florida
Investigational Site Number 8400031
Jacksonville, Florida
Investigational Site Number 8400022
Jacksonville, Florida
Investigational Site Number 8400098
Lake Mary, Florida
Investigational Site Number 8400058
Miami Beach, Florida
Investigational Site Number 8400105
Orlando, Florida
Investigational Site Number 8400082
Pensacola, Florida
Investigational Site Number 8400057
Port Charlotte, Florida
Investigational Site Number 8400006
Sarasota, Florida
Investigational Site Number 8400035
Tampa, Florida
Investigational Site Number 8400042
Tampa, Florida
Investigational Site Number 8400004
Wellington, Florida
Investigational Site Number 8400073
Atlanta, Georgia
Investigational Site Number 8400118
Tucker, Georgia
Investigational Site Number 8400067
Arlington Heights, Illinois
Investigational Site Number 8400043
Chicago, Illinois
Investigational Site Number 8400072
Elk Grove Village, Illinois
Investigational Site Number 8400055
Indianapolis, Indiana
Investigational Site Number 8400020
Muncie, Indiana
Investigational Site Number 8400122
Richmond, Indiana
Investigational Site Number 8400091
Waterloo, Iowa
Investigational Site Number 8400030
Covington, Louisiana
Showing 40 of 466 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.